Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pretransplant portal vein recanalization—transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis.Transplantation. 2015; 99: 2347-2355
- TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy.Hepatology. 2021; 74: 2735-2744
- Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?.Blood Coagul Fibrinolysis. 2005; 16: 329-335
- Hemostasis in liver disease.Semin Liver Dis. 1987; 7: 182-191
- Coagulation defects in liver disease.Med Clin North Am. 1994; 78: 545-554
- Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.Gut. 2005; 54: 691-697
- Incidence of portal vein thrombosis in liver cirrhosis.Gastroenterology. 1985; 89: 279-286
- Hypercoagulability in cirrhosis: causes and consequences.J Thromb Haemost. 2011; 9: 1713-1723
- Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer.Thromb Res. 2014; 134: 826-831
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.J Hepatol. 2004; 40: 736-741
- Portal vein thrombosis in liver transplantation.Transplant Proc. 2005; 37: 3904-3905
- The incidence of portal vein thrombosis at liver transplantation.Hepatology. 1992; 16: 1195-1198
- Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in Shiraz, Iran.Hepat Mon. 2015; 15: e26407
- Coagulopathy in liver diseases: complication or therapy?.Dig Dis. 2014; 32: 609-614
- Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.Thromb Haemost. 2010; 104: 741-749
- An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.Gastroenterology. 2009; 137: 2105-2111
- Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.J Hepatol. 2013; 59: 265-270
- Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study.Liver Int. 2017; 38: 94-101
- Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.J Hepatol. 2009; 51: 682-689
- Portal blood flow in cirrhosis of the liver.J Clin Invest. 1967; 46: 436-445
- Inflammation and portal hypertension: the undiscovered country.J Hepatol. 2014; 61: 155-163
- Ongoing prothrombotic state in the portal circulation of cirrhotic patients.Thromb Haemost. 1997; 77: 044-047
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.Thromb Res. 2008; 122: 299-306
- Portal vein thrombosis in adults undergoing liver transplantation.Transplantation. 2000; 69: 1873-1881
- Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.Hepatology. 2000; 31: 587-591
- Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis.Eur J Gastroenterol Hepatol. 1998; 10: A69
- Risk factors for thrombophilia in extrahepatic portal vein obstruction.Hepatology. 2005; 41: 603-608
- Etiology of portal vein thrombosis in adults.Gastroenterology. 1988; 94: 1063-1069
- Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms.J Thromb Haemost. 2011; 9: 2208-2214
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.Blood. 2008; 111: 4922-4929
- Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.Aliment Pharmacol Ther. 2011; 33: 1087-1103
- Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.J Gastroenterol Hepatol. 2012; 27: 1036-1043
- Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies.J Gastroenterol Hepatol. 2013; 28: 432-442
- Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.Hepatology. 2009; 51: 210-218
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012; 142: 1698-1704
- EASL Clinical Practice Guidelines: Vascular diseases of the liver.J Hepatol. 2016; 64: 179-202
- Guidance for the management of venous thrombosis in unusual sites.J Thromb Thrombolysis. 2016; 41: 129-143
- American Association for the Study Liver D. Vascular disorders of the liver.Hepatology (Baltimore, Md). 2009; 49: 1729-1764
- Concepts and controversies in haemostasis and thrombosis associated with liver disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.Thromb Haemost. 2018; 118: 1491-1506
- Guidelines on the investigation and management of venous thrombosis at unusual sites.Br J Haematol. 2012; 159: 28-38
- Update on management of portal vein thrombosis and the role of novel anticoagulants.J Clin translational Hepatol. 2019; 7: 154-164
- Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.Ann Gastroenterol. 2018; 31: 315-329
- Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis.Gastroenterology. 2017; 153: 480-487.e1
- Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.Clin Gastroenterol Hepatol. 2012; 10: 776-783
- Nontumoral portal vein thrombosis in patients awaiting liver transplantation.Liver Transplant. 2016; 22: 352-365
- Hypercoagulation and thrombophilia in liver disease.J Thromb Haemost. 2007; (070924041816002)https://doi.org/10.1111/j.1538-7836.2007.02772.x
- The complex role of anticoagulation in cirrhosis: an updated review of where we are and where we are going.Digestion. 2016; 93: 149-159
- Deciphering mesenteric venous thrombosis: imaging and treatment.Vasc Endovascular Surg. 2005; 39: 473-479
- Mesenteric vein thrombosis can be safely treated with anticoagulation but is associated with significant sequelae of portal hypertension.J Vasc Surg Venous Lymphatic Disord. 2016; 4: 400-406
- Mesenteric venous thrombosis: a changing clinical entity.J Vasc Surg. 2001; 34: 680-684
- Epidemiology, risk and prognostic factors in mesenteric venous thrombosis.Br J Surg. 2008; 95: 1245-1251
- Diagnosis and management of mesenteric infarction.Br J Surg. 1990; 77: 601-603
- Mesenteric venous thrombosis.N Engl J Med. 2001; 345: 1683-1688
- Acute superior mesenteric venous thrombosis: one disease or two?.Am J Gastroenterol. 2003; 98: 1299-1304
- Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome.HPB (Oxford). 2007; 9: 352-356
- Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality.Clin Transplant. 2007; https://doi.org/10.1111/j.1399-0012.2007.00728.x
- Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China.Transplant Proc. 2009; 41: 3761-3765
- Portal vein thrombosis and liver transplant survival benefit.Liver Transplant. 2010; 16: 999-1005
- Survival Outcomes Following Liver Transplantation (SOFT) Score: a novel method to predict patient survival following liver transplantation.Am J Transplant. 2008; 8: 2537-2546
- Long-term survival after portal vein arterialization for portal vein thrombosis in orthotopic liver transplantation.Gastroenterol Clin Biol. 2010; 34: 23-28
- Liver transplantation using cavoportal hemitransposition: a possibility in the presence of extensive portal vein thrombosis.Transplant Proc. 2001; 33: 2495-2496
- Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center.Transplant Proc. 2005; 37: 1119-1121
- Eversion thrombectomy for portal vein thrombosis during liver transplantation.Am J Transplant. 2002; 2: 934-938
- Liver transplantation in patients with portal vein thrombosis.Liver Transplant. 2001; 7: 125-131
- Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations.Tech Vasc Interv Radiol. 2016; 19: 52-60
- Portal vein recanalization-transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis.J Vasc Interv Radiol. 2015; 26: 499-506
- Combined transmesenteric and transhepatic recanalization of chronic portal and mesenteric vein occlusion to treat bleeding duodenal varices.J Vasc Interv Radiol. 2014; 25: 1295-1299
- Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach.Cardiovasc Intervent Radiol. 1996; 19: 352-355
- Percutaneous transmesenteric portal vein recanalization and transjugular direct intrahepatic portosystemic shunt creation for chronic portal vein occlusion.J Vasc Interv Radiol. 2019; 30: 892-893
- Percutaneous ultrasound-guided superior and inferior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt: a case series.Cardiovasc Intervent Radiol. 2021; 44: 496-499
- Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort.J Vasc Interv Radiol. 2017; 28: 1714-1721.e2
- Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis.J Vasc Interv Radiol. 2005; 16: 651-661
- Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis.World J Gastroenterol. 2009; 15: 5028-5034
- Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis.J Vasc Surg. 2002; 36: 1058-1061
- Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.Dig Liver Dis. 2017; 49: 1345-1352
- Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route.Abdom Imaging. 2011; 36: 390-398
- Baveno VII: renewing consensus in portal hypertension.J Hepatol. 2021; https://doi.org/10.1016/j.jhep.2021.12.022
Article info
Footnotes
Conflicts of interest: None.
Financial disclosures: None.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
